Detalles de la búsqueda
1.
Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer.
Pharmacoecon Open
; 6(6): 811-822, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036344
2.
The Role of Vector Trait Variation in Vector-Borne Disease Dynamics.
Front Ecol Evol
; 82020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32775339
3.
Correction to: Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer.
Pharmacoecon Open
; 6(6): 899, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36107308
Resultados
1 -
3
de 3
1
Próxima >
>>